Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14253 | 29504312 | J Zhejiang Univ Sci B | Role of exosome-associated microRNA in diagnostic and therapeutic applications to metabolic disorders. | 2018 | Details |
| A14254 | 29503789 | Curr Hepatol Rep | Managing the Burden of Non-NASH NAFLD. | 2017 | Details |
| A14260 | 29498345 | Br J Nutr | 20-Week follow-up of hepatic steatosis installation and liver mitochondrial structure and activity and their interrelation in rats fed a high-fat-high-fructose diet. | 2018 | Details |
| A14261 | 29497783 | Diabetologia | Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. | 2018 | Details |
| A14270 | 29491146 | J Biol Chem | Mice lacking ARV1 have reduced signs of metabolic syndrome and non-alcoholic fatty liver disease. | 2018 | Details |
| A14277 | 29487137 | Genetics | Seven-Up Is a Novel Regulator of Insulin Signaling. | 2018 | Details |
| A14280 | 29485130 | Am J Gastroenterol | The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth. | 2018 | Details |
| A14281 | 29484808 | Diabetes Obes Metab | Effects of resveratrol supplementation on liver fat content in overweight and insulin-resistant subjects: A randomized, double-blind, placebo-controlled clinical trial. | 2018 | Details |
| A14285 | 29483369 | Biosci Rep | Maternal obesity increases the risk of metabolic disease and impacts renal health in offspring. | 2018 | Details |
| A14289 | 29481986 | J Nutr Biochem | Replacement of soybean oil by fish oil increases cytosolic lipases activities in liver and adipose tissue from rats fed a high-carbohydrate diets. | 2018 | Details |
| A14295 | 29477657 | Eur J Pharmacol | Berberine induces miR-373 expression in hepatocytes to inactivate hepatic steatosis associated AKT-S6 kinase pathway. | 2018 | Details |
| A14306 | 29471595 | Diabetes Metab Res Rev | Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease. | 2018 | Details |
| A14312 | 29470286 | J Pediatr Gastroenterol Nutr | Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14317 | 29469051 | Ann Hepatol | Nonalcoholic Fatty Liver Disease Progresses into Severe NASH when Physiological Mechanisms of Tissue Homeostasis Collapse. | 2018 | Details |
| A14323 | 29466466 | PLoS One | Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach. | 2018 | Details |
| A14331 | 29463026 | Nutrients | The Nile Rat (Arvicanthis niloticus) as a Superior Carbohydrate-Sensitive Model for Type 2 Diabetes Mellitus (T2DM). | 2018 | Details |
| A14340 | 29456698 | Exp Ther Med | Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus. | 2018 | Details |
| A14344 | 29454969 | Biochem Biophys Res Commun | JIP3 knockout protects mice against high fat diet-induced liver injury. | 2018 | Details |
| A14345 | 29454967 | Biochem Biophys Res Commun | SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation. | 2018 | Details |
| A14358 | 29450137 | Biochim Open | Liver and Metformin: Lessons of a fructose diet in mice. | 2017 | Details |
| A14365 | 29445657 | Med J Islam Repub Iran | Correlation of visfatin level with non-alcoholic fatty liver in metabolic syndrome. | 2017 | Details |
| A14371 | 29441342 | Can J Gastroenterol Hepatol | Outcomes following Serial Intragastric Balloon Therapy for Obesity and Nonalcoholic Fatty Liver Disease in a Single Centre. | 2017 | Details |
| A14374 | 29439143 | Biosci Rep | Anarchy in the UPR: A Ca2+-insensitive PKC inhibits SERCA activity to promote ER stress. | 2018 | Details |
| A14376 | 29438686 | J Pediatr (Rio J) | Evaluation of nonalcoholic fatty liver disease using magnetic resonance in obese children and adolescents. | 2018 | Details |
| A14385 | 29432786 | Biochimie | Oleic acid induces the novel apolipoprotein O and reduces mitochondrial membrane potential in chicken and human hepatoma cells. | 2018 | Details |
| A14390 | 29431403 | Am Fam Physician | Mildly Elevated Liver Transaminase Levels: Causes and Evaluation. | 2017 | Details |
| A14393 | 29429367 | Arch Physiol Biochem | Obestatin protects and reverses nonalcoholic fatty liver disease and its associated insulin resistance in rats via inhibition of food intake, enhancing hepatic adiponectin signaling, and blocking ghrelin acylation. | 2018 | Details |
| A14395 | 29428667 | Biomed Pharmacother | Silybum marianum oil attenuates hepatic steatosis and oxidative stress in high fat diet-fed mice. | 2018 | Details |
| A14400 | 29427492 | Liver Int | Future therapy for non-alcoholic fatty liver disease. | 2018 | Details |
| A14404 | 29426937 | Nat Commun | Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. | 2018 | Details |
| A14407 | 29425212 | PLoS One | Insulin resistance in lean and overweight non-diabetic Caucasian adults: Study of its relationship with liver triglyceride content, waist circumference and BMI. | 2018 | Details |
| A14408 | 29424123 | J Gastroenterol Hepatol | Mouse models of non-alcoholic steatohepatitis: A reflection on recent literature. | 2018 | Details |
| A14409 | 29421523 | Transl Res | Maraviroc improves hepatic triglyceride content but not inflammation in a murine nonalcoholic fatty liver disease model induced by a chronic exposure to high-fat diet. | 2018 | Details |
| A14411 | 29420066 | Am J Physiol Gastrointest Liver Physiol | CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. | 2018 | Details |
| A14413 | 29419350 | Ultrastruct Pathol | Swim exercise training ameliorates hepatocyte ultrastructural alterations in rats fed on a high fat and sugar diet. | 2018 | Details |
| A14417 | 29416063 | Nat Commun | AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle. | 2018 | Details |
| A14420 | 29414781 | J Biol Chem | Maresin 1 attenuates NAFLD by suppression of endoplasmic reticulum stress via AMPK-SERCA2b pathway. | 2018 | Details |
| A14422 | 29414249 | Annu Rev Pathol | Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A14426 | 29411334 | J Cell Commun Signal | Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes. | 2018 | Details |
| A14428 | 29411128 | Eur J Appl Physiol | Effects of sprint interval training on ectopic lipids and tissue-specific insulin sensitivity in men with non-alcoholic fatty liver disease. | 2018 | Details |
| A14431 | 29409822 | Metabolism | Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults. | 2018 | Details |
| A14432 | 29409538 | BMC Res Notes | Laboratory parameters in lean NAFLD: comparison of subjects with lean NAFLD with obese subjects without hepatic steatosis. | 2018 | Details |
| A14435 | 29408694 | J Hepatol | Fructose and sugar: A major mediator of non-alcoholic fatty liver disease. | 2018 | Details |
| A14444 | 29404514 | Hepatol Commun | Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice. | 2017 | Details |
| A14450 | 29404483 | Hepatol Commun | Characteristics of hepatic insulin-sensitive nonalcoholic fatty liver disease. | 2017 | Details |
| A14453 | 29404440 | Hepatol Commun | Engineered FGF19 eliminates bile acid toxicity and lipotoxicity leading to resolution of steatohepatitis and fibrosis in mice. | 2017 | Details |
| A14460 | 29400692 | J Clin Invest | Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer. | 2018 | Details |
| A14467 | 29399273 | World J Hepatol | Role of inflammatory response in liver diseases: Therapeutic strategies. | 2018 | Details |
| A14469 | 29398867 | World J Gastroenterol | Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity/nonalcoholic fatty liver disease model in mice. | 2018 | Details |
| A14471 | 29398414 | Dig Liver Dis | Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects. | 2017 | Details |
| A14474 | 29396908 | Mol Nutr Food Res | Mice Fed a High-Cholesterol Diet Supplemented with Quercetin-3-Glucoside Show Attenuated Hyperlipidemia and Hyperinsulinemia Associated with Differential Regulation of PCSK9 and LDLR in their Liver and Pancreas. | 2018 | Details |
| A14476 | 29395967 | Growth Horm IGF Res | Factors correlated with serum insulin-like growth factor-I levels in health check-up subjects. | 2018 | Details |
| A14482 | 29391015 | Environ Health | Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003-2010. | 2018 | Details |
| A14489 | 29386155 | Pak J Pharm Sci | Therapeutic effect of alkaloids and glycosides of colocynth seeds on liver injury, associated with metabolic syndrome in wistar rats, subject to nutritional stress. | 2018 | Details |
| A14494 | 29382663 | Diabetes | Long Noncoding RNA lncSHGL Recruits hnRNPA1 to Suppress Hepatic Gluconeogenesis and Lipogenesis. | 2018 | Details |
| A14495 | 29381809 | Hepatology | Tumor Progression Locus 2 in Hepatocytes Potentiates Both Liver and Systemic Metabolic Disorders in Mice. | 2018 | Details |
| A14496 | 29381754 | PLoS One | Screening for nonalcoholic steatohepatitis by using cytokeratin 18 and transient elastography in HIV mono-infection. | 2018 | Details |
| A14504 | 29378152 | Can J Physiol Pharmacol | Beneficial effects of N-acetylcysteine on hepatic oxidative stress in streptozotocin-induced diabetic rats. | 2018 | Details |
| A14508 | 29377201 | Ann N Y Acad Sci | Cardiometabolic risk in obese children. | 2018 | Details |
| A14510 | 29376471 | Adipocyte | Emerging roles of SGLT2 inhibitors in obesity and insulin resistance: Focus on fat browning and macrophage polarization. | 2018 | Details |
| A14519 | 29371918 | Oncotarget | Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis. | 2017 | Details |
| A14520 | 29371773 | Indian J Clin Biochem | The Effects of Onion Consumption on Prevention of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14534 | 29364302 | Food Funct | Effects of a combined intervention with a lentil protein hydrolysate and a mixed training protocol on the lipid metabolism and hepatic markers of NAFLD in Zucker rats. | 2018 | Details |
| A14535 | 29364093 | Acta Gastroenterol Belg | The role of insulin - like growth factor - 1 on steatohepatitis. | 2018 | Details |
| A14537 | 29363914 | Pol J Pathol | Expression of resistin in the liver of patients with non-alcoholic fatty liver disease. | 2018 | Details |
| A14539 | 29363040 | Drugs | Semaglutide: First Global Approval. | 2018 | Details |
| A14540 | 29362454 | Sci Rep | Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance. | 2018 | Details |
| A14542 | 29361464 | Cell Syst | Integration of Multi-omics Data from Mouse Diversity Panel Highlights Mitochondrial Dysfunction in Non-alcoholic Fatty Liver Disease. | 2018 | Details |
| A14550 | 29358945 | PPAR Res | Peroxisome Proliferator-Activated Receptors Associated with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14552 | 29357809 | Cardiovasc Hematol Agents Med Chem | Coagonist of GLP-1 and Glucagon Receptor Ameliorates Development of Non-Alcoholic Fatty Liver Disease. | 2018 | Details |
| A14559 | 29354946 | Zhongguo Zhen Jiu | [Mechanisms of acupuncture for non-alcoholic fatty liver disease: researches progress and prospects]. | 2018 | Details |
| A14563 | 29353208 | Biomed Pharmacother | Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin. | 2018 | Details |
| A14564 | 29351486 | Am J Physiol Endocrinol Metab | Different physiological roles of insulin receptors in mediating nutrient metabolism in zebrafish. | 2017 | Details |
| A14570 | 29349944 | J Korean Med Sci | Investigation of Clinical and Pathological Relationships between Adult- and Pediatric-type NASH in Korean Children. | 2018 | Details |
| A14573 | 29348103 | Pak J Pharm Sci | Prevalence of non alcoholic fatty liver and Non alcoholic Steatohepatitis in Peshawar Cantonment, Khyber Pakhtunkhwa, Pakistan. | 2018 | Details |
| A14576 | 29344336 | Ther Adv Endocrinol Metab | Treating nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: a review of efficacy and safety. | 2017 | Details |
| A14582 | 29341349 | Pathol Int | Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease. | 2018 | Details |
| A14583 | 29341046 | Horm Metab Res | Reduced Growth Hormone Secretion is Associated with Nonalcoholic Fatty Liver Disease in Obese Children. | 2018 | Details |
| A14585 | 29338271 | Rev Esp Enferm Dig | Analytical, anthropometric and dietary factors associated with the development of fibrosis in patients with nonalcoholic fatty liver disease. | 2018 | Details |
| A14604 | 29327118 | Sleep Breath | Effect of CPAP therapy on liver disease in patients with OSA: a review. | 2018 | Details |
| A14605 | 29327078 | Cell Mol Life Sci | The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker? | 2018 | Details |
| A14609 | 29325294 | Zhonghua Gan Zang Bing Za Zhi | [Effects of Lactobacillus paracasei N1115 combined with fructooligosaccharides on non-alcoholic fatty liver disease induced by high-fat diet in mice]. | 2017 | Details |
| A14620 | 29321172 | Diabetes | Modest Decreases in Endogenous All-trans-Retinoic Acid Produced by a Mouse Rdh10 Heterozygote Provoke Major Abnormalities in Adipogenesis and Lipid Metabolism. | 2018 | Details |
| A14622 | 29319180 | J Cell Physiol | WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling. | 2018 | Details |
| A14635 | 29314568 | Liver Int | Genetic determinants of hepatic steatosis and serum cytokeratin-18 fragment levels in Taiwanese children. | 2018 | Details |
| A14642 | 29311481 | Biol Pharm Bull | A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation. | 2018 | Details |
| A14665 | 29298969 | Pol Merkur Lekarski | [Dietetary recommendation for non-alcoholic fatty liver disease]. | 2017 | Details |
| A14668 | 29295869 | Endocr Connect | Macrophage activation marker sCD163 correlates with accelerated lipolysis following LPS exposure: a human-randomised clinical trial. | 2018 | Details |
| A14669 | 29295591 | Nutrients | Leonurus japonicus Houtt Attenuates Nonalcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Cells and Mice Fed a High-Fat Diet. | 2017 | Details |
| A14671 | 29294263 | Postepy Biochem | [NAFLD pathogenesis in the light of recent research]. | 2019 | Details |
| A14674 | 29291351 | Nat Med | The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. | 2018 | Details |
| A14677 | 29291018 | Oncotarget | Serum fetuin A level is associated with nonalcoholic fatty liver disease in Chinese population. | 2017 | Details |
| A14683 | 31213752 | Hippokratia | Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease. | 2020 | Details |
| A14692 | 29287685 | Pharmacol Res | Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review. | 2017 | Details |
| A14700 | 29281159 | Eur J Neurol | Non-alcoholic fatty liver disease is associated with stroke severity and progression of brainstem infarctions. | 2018 | Details |
| A14704 | 29280273 | J Intern Med | Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver. | 2017 | Details |
| A14711 | 29276754 | Cell Mol Gastroenterol Hepatol | Uncovering a Predictive Molecular Signature for the Onset of NASH-Related Fibrosis in a Translational NASH Mouse Model. | 2017 | Details |
| A14713 | 29276215 | Exp Anim | Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis. | 2017 | Details |
| A14720 | 29271970 | AIDS Rev | Non-Alcoholic Fatty Liver Disease and HIV/AIDS: A New Way of Modulation of Cardiovascular Risk. | 2018 | Details |
| A14721 | 29271886 | Nutrients | A Combination of Coffee Compounds Shows Insulin-Sensitizing and Hepatoprotective Effects in a Rat Model of Diet-Induced Metabolic Syndrome. | 2017 | Details |